<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR14">
 <label>14.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Verstovsek</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase 3 randomized trial of Momelotinib versus best available therapy in patients with myelofibrosis previously treated with Ruxolitinib: results of the Simplify-2 study</article-title>
  <source>Haematologica</source>
  <year>2017</year>
  <volume>102</volume>
  <fpage>320</fpage>
  <lpage>321</lpage>
  <pub-id pub-id-type="doi">10.3324/haematol.2016.147843</pub-id>
  <pub-id pub-id-type="pmid">27658438</pub-id>
 </element-citation>
</ref>
